S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?

Envista (NVST) Stock Price, News & Analysis

$21.39
-0.16 (-0.74%)
(As of 03/28/2024 ET)
Today's Range
$21.24
$21.62
50-Day Range
$20.64
$24.53
52-Week Range
$20.00
$40.92
Volume
1.38 million shs
Average Volume
2.40 million shs
Market Capitalization
$3.67 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$29.60

Envista MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
38.4% Upside
$29.60 Price Target
Short Interest
Bearish
5.10% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
0.90mentions of Envista in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.99%
From $1.43 to $1.63 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.51 out of 5 stars

Medical Sector

128th out of 938 stocks

Dental Equipment & Supplies Industry

2nd out of 3 stocks

NVST stock logo

About Envista Stock (NYSE:NVST)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

NVST Stock Price History

NVST Stock News Headlines

NVST Envista Holdings Corporation
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Piper Sandler Keeps Their Hold Rating on Envista Holdings (NVST)
Envista (NVST) Q4 Earnings Miss Estimates, Margins Down
See More Headlines
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/07/2024
Today
3/28/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Employees
12,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$29.60
High Stock Price Target
$45.00
Low Stock Price Target
$19.00
Potential Upside/Downside
+38.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
11 Analysts

Profitability

Net Income
$-100,200,000.00
Pretax Margin
-2.14%

Debt

Sales & Book Value

Annual Sales
$2.57 billion
Cash Flow
$2.62 per share
Book Value
$24.35 per share

Miscellaneous

Free Float
169,491,000
Market Cap
$3.67 billion
Optionable
Optionable
Beta
1.35
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

NVST Stock Analysis - Frequently Asked Questions

Should I buy or sell Envista stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Envista in the last year. There are currently 3 sell ratings, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NVST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVST, but not buy additional shares or sell existing shares.
View NVST analyst ratings
or view top-rated stocks.

What is Envista's stock price target for 2024?

11 brokers have issued 12 month target prices for Envista's stock. Their NVST share price targets range from $19.00 to $45.00. On average, they predict the company's share price to reach $29.60 in the next year. This suggests a possible upside of 38.4% from the stock's current price.
View analysts price targets for NVST
or view top-rated stocks among Wall Street analysts.

How have NVST shares performed in 2024?

Envista's stock was trading at $24.06 at the start of the year. Since then, NVST shares have decreased by 11.1% and is now trading at $21.39.
View the best growth stocks for 2024 here
.

Are investors shorting Envista?

Envista saw a decline in short interest in the month of February. As of February 15th, there was short interest totaling 8,180,000 shares, a decline of 17.1% from the January 31st total of 9,870,000 shares. Based on an average daily volume of 2,520,000 shares, the days-to-cover ratio is presently 3.2 days.
View Envista's Short Interest
.

When is Envista's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our NVST earnings forecast
.

How were Envista's earnings last quarter?

Envista Holdings Co. (NYSE:NVST) issued its quarterly earnings results on Wednesday, February, 7th. The company reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.33 by $0.04. The business earned $645.60 million during the quarter, compared to analysts' expectations of $638.37 million. Envista had a negative net margin of 3.90% and a positive trailing twelve-month return on equity of 6.31%. The firm's revenue was down 2.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.52 earnings per share.

What is Amir Aghdaei's approval rating as Envista's CEO?

9 employees have rated Envista Chief Executive Officer Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among the company's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When did Envista IPO?

Envista (NVST) raised $603 million in an initial public offering (IPO) on Wednesday, September 18th 2019. The company issued 26,800,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Who are Envista's major shareholders?

Envista's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.02%), Vanguard Group Inc. (10.01%), Dimensional Fund Advisors LP (3.79%), Massachusetts Financial Services Co. MA (3.32%), Franklin Resources Inc. (3.07%) and Nuance Investments LLC (2.29%). Insiders that own company stock include Amir Aghdaei, Curt W Bludworth, Curt W Bludworth, Eric Conley, Howard H Yu, Jeffrey Kappler, Mark E Nance, Mark E Nance, Mischa Reis and Stephen Keller.
View institutional ownership trends
.

How do I buy shares of Envista?

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NVST) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners